Condition

Inflammatory Bowel Disease

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 16 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials16
Recruiting4
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

16 shown
COVID-19 Booster and IIV Schedule in Immunocompromised HostsNCT06599658 · 2024-11-20
RECRUITING
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNCT04751396 · 2022-04-20
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345 · 2019-07-16
RECRUITING
Health and Exercise Response in Children With Chronic and Auto-immune PathologiesNCT03913962 · 2019-05-02
RECRUITING
Integrating Vaccination Into Hospital Care Pathways for Vulnerable PatientsNCT07391046 · 2026-02-01
NOT_YET_RECRUITING
A Clinical Study to Evaluate SM17 in Healthy ParticipantsNCT07466940 · 2025-10-14
COMPLETED
Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal DiseasesNCT04924686 · 2020-05-10
UNKNOWN
A Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid ArthritisNCT02463916 · 2015-03-01
UNKNOWN
Effects of Fasting on Self EfficacyNCT02113111 · 2014-04-01
COMPLETED
25-hydroxyvitamin D and Fatigue: The VITALITY StudyNCT01718925 · 2012-10-01
COMPLETED
Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive AnalysisNCT02922192 · 2012-01-01
COMPLETED
SurgicAl Metabolic Phenotyping Longitudinal Evaluation StudyNCT01378013 · 2011-08-01
COMPLETED
Prognostic Indicators as Provided by the EPIC ClearViewNCT01476995 · 2010-09-01
COMPLETED
MD2Me - Texting to Promote Chronic Disease ManagementNCT01253733 · 2009-10-01
COMPLETED
Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and PsoriasisNCT00658827 · 2007-01-01
COMPLETED
Sirolimus for Autoimmune Disease of Blood CellsNCT00392951 · 2006-12-01
COMPLETED

Common interventions

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

Leading sponsors

Trial status mix

COMPLETED9
RECRUITING4
UNKNOWN2
NOT_YET_RECRUITING1

Phase mix

PHASE13
PHASE23
NA2
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.